IDiyas

For the Inventor, By the Inventor

Stonington, CT, United States of America

Stephen Anderson

USPTO Granted Patents = 11

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 59(Granted Patents)


Company Filing History:

goldMedal11 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 2020-2025

Loading Chart...
11 patents (USPTO):
1. 12297177 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2025-05-13),
2. 12116347 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-10-15),
3. 11905255 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-02-20),
4. 11884635 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-01-30),
5. 11884634 - Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide (2024-01-30),
6. 11845732 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-12-19),
7. 11820748 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-11-21),
8. 11566006 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-01-31),
9. 10941118 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2021-03-09),
10. 10710966 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2020-07-14),
11. 10590087 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2020-03-17),

Title: Stephen Anderson: Pioneering Inventor Shaping the Future of Technology

Introduction:

Stephen Anderson, a trailblazing inventor based in Stonington, CT, has left an indelible mark on the world of technology with his relentless drive for innovation and passion for pushing boundaries.

Latest Patents:

With an impressive total of 9 patents to his name, Stephen's latest groundbreaking invention is in the field of pharmaceuticals. He has developed solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and its uses.

Career Highlights:

Stephen Anderson is currently making waves at Pfizer Corporation, where his innovative spirit thrives. His ability to think outside the box and create solutions that impact lives sets him apart in the industry.

Collaborations:

In his journey of innovation, Stephen has collaborated with esteemed colleagues Elaine Greer and Mark Maloney. Together, they have advanced the boundaries of what is possible in the realm of pharmaceuticals and medical treatment.

Conclusion:

Stephen Anderson's legacy as a pioneering inventor is secure, with each patent and invention solidifying his reputation as a visionary in the field of technology. His relentless pursuit of innovation continues to shape the future, making him a true trailblazer in the world of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…